| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |